QUEST DIAGNOSTICS INC

DGX stock represents shares of Quest Diagnostics Incorporated, a leading U.S. provider of diagnostic testing, information, and services. The company operates clinical laboratories and offers a broad range of tests for patients, physicians, hospitals, and health plans. DGX trades on the New York Stock Exchange, giving investors exposure to the healthcare diagnostics sector through a single equity security.

DGX operates within the healthcare sector, specifically in the medical diagnostics and clinical laboratory services industry. The company provides diagnostic testing services, including routine blood work, anatomic pathology, and advanced molecular testing. This industry is characterized by regulatory oversight, reliance on reimbursement from insurers and government programs, and ongoing demand tied to patient care and disease detection.

The latest price for DGX stock fluctuates during each trading session based on market activity. For the most accurate and current quote, please refer to the live price displayed on this page or your brokerage platform. That figure reflects real-time trading data and is more reliable than any static number.

DGX stock volatility generally reflects broader healthcare sector trends, company-specific news, and changes in reimbursement policies or testing volumes. Volatility can rise around earnings releases or regulatory announcements. Historical price swings are not a guarantee of future movement, so checking the current data and recent trading range on this page helps provide context for its typical behavior.

Common valuation metrics for DGX include the price-to-earnings ratio, price-to-sales ratio, and EV/EBITDA, each helping compare its market price to financial fundamentals. Analysts may also consider free cash flow yield and dividend-adjusted metrics. Because valuation depends on earnings, growth prospects, and industry conditions, reviewing multiple metrics alongside the latest DGX financials provides a more balanced picture.

Analyzing DGX involves reviewing its income statement, balance sheet, and cash flow statement to assess revenue trends, margins, and profitability. Key metrics include revenue growth, operating margin, earnings per share, and free cash flow. Comparing these figures across multiple quarters and against industry peers helps investors understand how efficiently DGX converts testing volume into earnings and cash.